117 related articles for article (PubMed ID: 25855954)
21. Stratifin expression is a novel prognostic factor in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas.
Kobayashi T; Masumoto J; Tada T; Nomiyama T; Hongo K; Nakayama J
Clin Cancer Res; 2007 Jul; 13(13):3868-74. PubMed ID: 17606719
[TBL] [Abstract][Full Text] [Related]
23. Expression of metastasis-associated protein 3 in human brain glioma related to tumor prognosis.
Shan S; Hui G; Hou F; Shi H; Zhou G; Yan H; Wang L; Liu J
Neurol Sci; 2015 Oct; 36(10):1799-804. PubMed ID: 26002011
[TBL] [Abstract][Full Text] [Related]
24. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival.
Ding L; Sun X; You Y; Liu N; Fu Z
Transl Res; 2010 Jul; 156(1):45-52. PubMed ID: 20621036
[TBL] [Abstract][Full Text] [Related]
25. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration.
Xu L; Li Q; Xu D; Wang Q; An Y; Du Q; Zhang J; Zhu Y; Miao Y
Int J Oncol; 2014 Feb; 44(2):459-66. PubMed ID: 24285464
[TBL] [Abstract][Full Text] [Related]
26. Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.
Wang L; Yuan J; Tu Y; Mao X; He S; Fu G; Zong J; Zhang Y
Clin Transl Oncol; 2013 Feb; 15(2):139-45. PubMed ID: 22855183
[TBL] [Abstract][Full Text] [Related]
27. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
Li S; Yang B; Li G; He S; Li Y
Brain Tumor Pathol; 2013 Jan; 30(1):8-14. PubMed ID: 22399192
[TBL] [Abstract][Full Text] [Related]
29. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
[TBL] [Abstract][Full Text] [Related]
30. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
31. Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma.
He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
Brain Tumor Pathol; 2012 Jan; 29(1):3-9. PubMed ID: 21837501
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of PCDH9 predicts prognosis for patients with glioma.
Wang C; Yu G; Liu J; Wang J; Zhang Y; Zhang X; Zhou Z; Huang Z
J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792
[TBL] [Abstract][Full Text] [Related]
33. A multivariate analysis of the prognostic factors of grade III gliomas.
Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
[TBL] [Abstract][Full Text] [Related]
34. Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.
Akiyama Y; Komiyama M; Miyata H; Yagoto M; Ashizawa T; Iizuka A; Oshita C; Kume A; Nogami M; Ito I; Watanabe R; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Apr; 31(4):1683-90. PubMed ID: 24573400
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.
Liu H; Liu B; Hou X; Pang B; Guo P; Jiang W; Ding Q; Zhang R; Xin T; Guo H; Xu S; Pang Q
J Neurooncol; 2017 May; 132(3):409-417. PubMed ID: 28321704
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis.
He S; Ding L; Cao Y; Li G; Deng J; Tu Y; Wang B
Med Oncol; 2012 Sep; 29(3):2032-7. PubMed ID: 21983884
[TBL] [Abstract][Full Text] [Related]
37. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
Tu Y; Lu J; Fu J; Cao Y; Fu G; Kang R; Tian X; Wang B
Jpn J Clin Oncol; 2010 May; 40(5):388-94. PubMed ID: 20304779
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
[TBL] [Abstract][Full Text] [Related]
39. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas.
Zhang Y; Zhan H; Xu W; Yuan Z; Lu P; Zhan L; Li Q
Pathol Res Pract; 2011 Jan; 207(1):24-9. PubMed ID: 21087829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]